Mi. Koukourakis et al., Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy, CLIN CANC R, 7(11), 2001, pp. 3399-3403
Purpose: Carbonic anhydrases are proteins involved in the catalytic hydrati
on of carbon dioxide to carbonic acid. Recent studies show that carbonic an
hydrase 9 (CA9) is up-regulated by hypoxia and that its immunohistochemical
tissue distribution follows the distribution of the radiosensitizer pimoni
dazole (C. C. Wykoff et al., Cancer Res. 60: 7075-7083, 2001). Therefore, C
A9 expression may show hypoxia levels of clinical importance.
Experimental Design: We assessed the expression of CA9 and the microvessel
density (MVD; CD31-positive) in 75 locally advanced squamous cell head and
neck cancers treated with concurrent chemoradiotherapy with carboplatin.
Results: Strong membrane/cytoplasmic CA9 expression, noted in 20/75 (26.6%)
tumors, mainly occurred in tumors with very poor vascularization (expressi
on in 63% versus 14%; P < 0.0001), was located around areas of focal necros
is, and was related to poor complete response rate (40% versus 70%; P = 0.0
2). These observations suggested that CA9 might be a marker of clinically i
mportant hypoxia. Combining the CA9 staining and the tumor angiogenicity (M
VD), we identified three groups of patients: (a) hypoxic tumors; (b) euoxic
highly angiogenic tumors; and (c) euoxic non-highly angiogenic tumors. Gro
ups (a) and (b) had a very poor local relapse-free survival (P < 0.0001).
Conclusions: Stratification of patients undergoing radical radiotherapy usi
ng the CA9/MVD model may be useful for the individualization of therapeutic
strategies combining antiangiogenesis and hypoxia targeting with radiother
apy.